|Articles|December 29, 2015
Top Articles from Evidence-Based Diabetes Management for 2015
Author(s)Mary K. Caffrey
Stories about therapy, led by updates on Afrezza, were most popular with readers interested in diabetes care.
Advertisement
When it comes to diabetes care, reader preferences don’t always align with the market. The inhaled insulin Afrezza may be struggling with sales, but it’s a favorite with readers (and on social media, too). Articles about technology, drug pricing and approvals were also among the most-read items of the year for the publication, which pursued special issues on obesity, adherence, and innovation during 2015. Look for our upcoming issue, “All About Measurement,” early in 2016.
Internal server error